Home > Healthcare > Medical Devices > Implantable Devices > Coronary Artery Bypass Graft Market

Coronary Artery Bypass Graft Market Size

Report ID: GMI8564
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Coronary Artery Bypass Graft Market Size

The global coronary artery bypass graft market size was valued at USD 11.8 billion in 2023 and is estimated to grow at 7.1% CAGR from 2024 to 202. Coronary artery bypass graft (CABG) is a surgical procedure for treating coronary artery disease (CAD). The operation creates a new pathway for blood flow to the heart using a graft. This graft is typically a section of blood vessel taken from another part of the patient's body, such as the leg's saphenous vein or the chest's internal mammary artery.

To get key market trends

Download Free Sample

The coronary artery bypass graft (CABG) market is experiencing significant growth driven by the increasing global prevalence of coronary heart disease. According to the World Health Organization (WHO), cardiovascular disease remains the leading cause of death worldwide, claiming approximately 17.9 million lives annually. Additionally, the rising incidence of chronic conditions, such as diabetes and pulmonary arterial hypertension, further contributes to this market expansion. Elevated blood sugar levels can damage the blood vessels supplying the heart, thereby increasing the risk of cardiovascular diseases.

Coronary Artery Bypass Graft Market Report Attributes
Report Attribute	Details
Base Year:	2023
Coronary Artery Bypass Graft Market Size in 2023:	USD 11.8 Billion
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	7.1%
2032 Value Projection:	USD 21.5 Billion
Historical Data for:	2021 - 2023
No. of Pages:	150
Tables, Charts & Figures:	185
Segments covered:	Product, Method, Surgery Type, End Use, and Region
Growth Drivers:	Increasing in prevalence of cardiovascular diseases Growing technological advancement Rising prevalence of hypertension Favourable reimbursement scenario
Pitfalls & Challenges:	High cost associated with surgery procedures Complications associated with the surgery

Learn more about the key segments shaping this market

Download Free Sample

Moreover, the expanding geriatric population plays a significant role in market growth, with the United Nations projecting that this demographic will reach 2.1 billion by 2050, effectively doubling its current size. Older individuals are more vulnerable to cardiovascular diseases due to the gradual accumulation of fat deposits on artery walls, making CABG an essential intervention for this population. In addition to the geriatric population, favourable reimbursement policies are positively influencing the CABG market, enhancing accessibility, and encouraging the adoption of surgical procedures. Together, these factors underscore the growing importance of CABG in addressing the global burden of cardiovascular diseases.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market for coronary artery bypass graft was reached USD 11.8 billion in 2023 and is estimated to grow at a 7.1% CAGR from 2024 to 2032, driven by the increasing prevalence of cardiovascular diseases.

The traditional (on-pump) CABG segment dominated the market with a 55.1% revenue share in 2023, due to its established efficacy and widespread adoption in surgical practices.

The grafts segment was valued at over USD 3.1 billion in 2023, as these are essential components in CABG procedures.

The U.S. coronary artery bypass graft market surpassed USD 3.5 billion in 2023 and is expected to grow at a 6.7% CAGR through 2032, led by favorable reimbursement policies and advanced healthcare infrastructure.

Key players in the industry include Abbott Laboratories, AngioDynamics, AtriCure, B. Braun Melsungen AG, Boston Scientific, Cardinal Health, CryoLife, Edwards Lifesciences, Johnson & Johnson, LivaNova, Medline Industries, Medtronic, Nipro Corporation, Stryker Corporation, and Terumo Corporation.